Now this could be a game changer. With growing evidence that major psychiatric disorders such as schizophrenia, bipolar disorder, and major depression are linked to neuroinflammation, new treatments targeting this are emerging.

Now, this study is accepting recruits–in Ethiopia–and is unlikely to directly benefit Canadians.  That said, if it is positive, it will be a third good quality positive study and put minocycline on the map for treating schizophrenia.  For now, it is experimental and reserved for treatment resistent cases.

https://clinicaltrials.gov/show/NCT01809158

Sent from my iPad